Frequency News and Research

RSS

Past exposure to pathogens leads to disease resistance spreading through populations

A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.

24 Sep 2010

SAHA selects TeleTracking's RadarFind as exclusive real-time locating provider

The Southern Atlantic Healthcare Alliance (SAHA) has selected TeleTracking's RadarFind as the exclusive real-time locating provider for member hospitals. SAHA, which is comprised of 16 hospitals in North Carolina, chose RadarFind's real-time location system (RTLS) to enable their members to track medical equipment, patients and staff.

23 Sep 2010

Teleflex launches Gibeck Humid-Flo Passive Humidification Kit for Ventilator Associated Pneumonia risk reduction

Teleflex has introduced the Gibeck Humid-Flo Passive Humidification Kit, an integrated system that promotes best practices for Ventilator Associated Pneumonia (VAP) risk reduction. This convenient kit includes everything required to initiate passive humidification for the first 72 hours of mechanical ventilation.

23 Sep 2010

New Canadian book helps demystify the health care system

If your usual cure for what ails you is to "take two pills and call in the morning" you might be in need of some better medical advice. Take as Directed is a new book from Dalhousie University pharmacy professor Neil MacKinnon and Dal Medical School alumni Rhonda Church. Aimed at helping Canadians from all walks of life navigate the health care system, Take as Directed is essential reading for anybody who is concerned about their health and well being.

23 Sep 2010

Beta-Pro donates human pancreatic islet cells to diabetes researcher

The cellular services company Beta-Pro LLC, announced today that it donated more than 300,000 human pancreatic islet cells to nationally renowned diabetes researcher Raghavendra G. Mirmira, M.D., Ph.D., the Eli Lilly & Co. Professor of Pediatric Diabetes, Indiana University School of Medicine, Herman B.

23 Sep 2010

FDA approves Gilenya capsules for reducing MS relapses

The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).

22 Sep 2010

AMA launches new online tool to strengthen the financial health of physician practices

The American Medical Association (AMA) today announced a new online tool designed to help physician practices prepare for billing and payment audits by insurers and federal contractors. The AMA’s Practice Analysis Tools for Healthcare (AMA PATH™) puts self-auditing tools in the hands of physicians, allowing them to develop and evaluate fee schedules and billing safeguards without hiring an expensive consultant.

21 Sep 2010

Prostate cancer - TRAIL is worth a trial

One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.

21 Sep 2010

Methylphenidate drug prescriptions are on the rise

Hyperkinetic disorders among children and adolescents are becoming increasingly common. In the current issue of Deutsches Ärzteblatt International, Ingrid Schubert of the PMV Research Group at the University of Cologne and her colleagues address the question how this has affected the frequency of prescriptions for methylphenidate, a stimulant drug that is used to treat such disorders.

21 Sep 2010

Boston Scientific announces acquisition of Asthmatx

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Asthmatx, Inc., a privately held company in Sunnyvale, California. Asthmatx designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma in the 6 to 8 million patients 18 years and older worldwide whose asthma is not well controlled with drugs (inhaled medications).

20 Sep 2010

Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients

Bristol-Myers Squibb Company and AstraZeneca today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing glimepiride (sulphonylurea) therapy produced significant reductions in glycosylated hemoglobin levels (HbA1c) in adult patients with type 2 diabetes compared to glimepiride alone.

20 Sep 2010

Tiotropium bromide shows potential as an alternative asthma treatment

A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

20 Sep 2010

Research finds placebo improves sexual satisfaction among women

Many women with low sex drives reported greater sexual satisfaction after taking a placebo, according to new psychology research from The University of Texas at Austin and Baylor College of Medicine.

17 Sep 2010

Study finds no link between asthma and tooth decay

There is no apparent link between asthma and tooth decay, according to a study published in the September 2010 issue of the Journal of the American Dental Association.

17 Sep 2010

Researchers to develop new wearable sensor network to assess physical activity

Researchers from Michigan State University's departments of Electrical Engineering and Kinesiology are teaming up to create a new wearable sensor network to assess a person's physical activity and overall well-being.

15 Sep 2010

CINJ experts available for discussion during National Prostate Cancer Awareness Month

The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the risks, treatments and prevention options surrounding prostate cancer during September, which is National Prostate Cancer Awareness Month. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

15 Sep 2010

Burnout in medical students likely to self-report unprofessional conduct: Study

Medical students with higher levels of distress (burnout) were more likely to self-report unprofessional conduct related to patient care and less altruistic professional values, according to a study in the September 15 issue of JAMA, a theme issue on medical education.

15 Sep 2010

AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website

AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).

15 Sep 2010

Enlarged hearts regress faster in elderly women than in men after aortic valve replacement

Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association.

14 Sep 2010

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from the first of two Phase 3 clinical trials assessing the efficacy and safety of the investigational drug, linaclotide, in patients with irritable bowel syndrome with constipation (IBS-C).

14 Sep 2010

Frequency News and Research

Past exposure to pathogens leads to disease resistance spreading through populations

SAHA selects TeleTracking's RadarFind as exclusive real-time locating provider

Teleflex launches Gibeck Humid-Flo Passive Humidification Kit for Ventilator Associated Pneumonia risk reduction

New Canadian book helps demystify the health care system

Beta-Pro donates human pancreatic islet cells to diabetes researcher

FDA approves Gilenya capsules for reducing MS relapses

AMA launches new online tool to strengthen the financial health of physician practices

Prostate cancer - TRAIL is worth a trial

Methylphenidate drug prescriptions are on the rise

Boston Scientific announces acquisition of Asthmatx

Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients

Tiotropium bromide shows potential as an alternative asthma treatment

Research finds placebo improves sexual satisfaction among women

Study finds no link between asthma and tooth decay

Researchers to develop new wearable sensor network to assess physical activity

CINJ experts available for discussion during National Prostate Cancer Awareness Month

Burnout in medical students likely to self-report unprofessional conduct: Study

AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website

Enlarged hearts regress faster in elderly women than in men after aortic valve replacement

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News